Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Staudt
The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced Cardiomyopathy
Cancer Research
Cancer Research
Oncology
Related publications
Cardiopulmonary Dysfunction During Porcine Endotoxin Shock Is Effectively Counteracted by the Endothelin Receptor Antagonist Bosentan
Critical Care
Critical Care
Intensive Care Medicine
Potent Anti-Inflammatory and Antinociceptive Activity of the Endothelin Receptor Antagonist Bosentan in Monoarthritic Mice
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Doxorubicin Chronic Cardiomyopathy
Baylor University Medical Center Proceedings
Medicine
Anatomopathological Study of Cardiomyopathy Induced by Doxorubicin in Rats
Acta Cirurgica Brasileira
Surgery
Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Medicinal Research Reviews
Drug Discovery
Molecular Medicine
Pharmacology
Role of Endothelin in the Maintenance of Blood Pressure in Conscious Rats With Chronic Heart Failure. Acute Effects of the Endothelin Receptor Antagonist Ro 47-0203 (Bosentan)
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Bosentan Enhances in Vitro Bortezomib's Anti-Proliferative Potency Against Multiple Myeloma by Mechanisms Going Beyond Endothelin Receptor Blockade
British Journal of Haematology
Hematology
A Novel ETA-receptor Antagonist, FR 139317, Inhibits Endothelin-Induced Contractions of Guinea-Pig Pulmonary Arteries, but Not Trachea
British Journal of Pharmacology
Pharmacology
Stability-Indicating Gradient RP-LC Method for the Determination of Process and Degradation Impurities in Bosentan Monohydrate: An Endothelin Receptor Antagonist
Chromatography Research International
